Genesis Cancer Care Research Collaboration Agreement ...

Genesis Cancer Care Research Collaboration Agreement
 Collaboration with Australia’s largest provider of radiation oncology
 Research into the design and 3D print manufacture of patient-specific electron beam shields for use in radiotherapy treatment
 Pathway to a manufacturing agreement for personalised radiotherapy consumables
3D Medical Limited (ASX: 3DM) and Genesis Cancer Care, a division of Genesis Care, Australia’s largest private provider of radiation oncology, have signed a Research Collaboration Agreement as part of Genesis Care’s focus on delivering increasingly personalised medical treatment.
The Research Collaboration Agreement allows the parties to undertake joint testing and evaluation of 3D printing and workflow processes for the purpose of manufacturing patient-specific electron beam shields that are personalised to the specific requirements of each patient’s radiotherapy treatment. Subject to a successful outcome both parties will seek to enter a manufacture and supply relationship on commercial terms.
If successful, the collaboration will provide Genesis Cancer Care with enhanced workflows that will reduce the time to deliver radiotherapy treatments and deliver a highly personalised medical approach with improved patient outcomes.
Max Ghobrial CEO of 3DM commented, “We are delighted to have entered into this collaborative agreement with Genesis Cancer Care, Australia’s largest provider of radiotherapy. The projects to be completed during the investigative phase of the agreement involve a novel application of 3D printing technology. If successful this will reduce the cost to deliver patient care and increase the quality of patient outcomes. These outcomes are consistent with our objective to be the preferred partner for managing and utilising 3D imagery in the clinical setting”.